日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Sysmex, Gaudi Clinical Form Strategic Business Alliance
Sysmex Corporation and Gaudi Clinical Inc., have signed an agreement. This agreement…
MAMORUNO and BONX WORK partner on care monitoring
BONX Inc., developer of the one-stop solution for on-site communication “BONX WORK,”…
Rakuten Healthcare Launch Online Med Advice & Delivery
Rakuten Healthcare Yoyakusuri, a nationwide pharmacy reservation and medication record app operated…
GMO Reserve Plus launches AI-Board for medical analysis
GMO Reserve Plus, Inc., a GMO Internet Group company and consolidated subsidiary…
AriBio and Fujirebio Diagnostics Completes Sample Set
Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio Co.,…
Asada Clinic, IBM Japan Develop AI Chatbot for Infertility
Asada Ladies Clinic and IBM Japan announced that they had jointly developed…
Amprat and Digzyme Partner on Data and Enzyme Tech
Amplat Inc. is pleased to announce that it has begun a collaboration…
Medmain Raises $3.3M, Backed by One Capital and Others
Medmain Inc., a Japanese medtech startup that offers PidPort, an AI-powered cloud…
Latest Article
English